Randomized, double-blind, Multicenter study of the endeavor Zotarolimus-Eluting phosphorylcholine-encapsulated Stent for treatment of native coronary artery lesions - Long-term efficacy and safety of the ENDEAVOR II trial

被引：0
|
作者：
Konorza, T. F. M.
机构：
来源：
HERZ | 2007年 / 32卷 / 05期
关键词：
D O I：
10.1007/s00059-007-3033-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：428 / 428
页数：1
相关论文
共 50 条
  • [31] Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) Trial
    Serruys, PW
    Degertekin, M
    Tanabe, K
    Abizaid, A
    Sousa, JE
    Colombo, A
    Guagliumi, G
    Wijns, W
    Lindeboom, WK
    Ligthart, J
    de Feyter, PJ
    Morice, MC
    CIRCULATION, 2002, 106 (07) : 798 - 803
  • [32] ISR II study:: A long-term evaluation of sirolimus-eluting stent in the treatment of patients with in-stent restenotic native coronary artery lesions
    Commeau, P
    Barragan, PT
    Roquebert, PO
    Siméoni, JB
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 66 (02) : 158 - 162
  • [33] Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)
    Kandzari, David E.
    Mauri, Laura
    Popma, Jeffrey J.
    Turco, Mark A.
    Gurbel, Paul A.
    Fitzgerald, Peter J.
    Leon, Martin B.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (05) : 543 - 550
  • [34] Long-term Safety and Efficacy of Zotarolimus-eluting Stent versus Sirolimus-eluting Stent or Bare Metal Stent in Patients With STEMI Who Underwent Primary Percutaneous Coronary Intervention
    Koh, Yoon Seok
    CIRCULATION, 2009, 120 (18) : S972 - S972
  • [35] Optimal Duration of Dual Antiplatelet Therapy Following Treatment with the Endeavor Zotarolimus-Eluting Stent in Real-World Japanese Patients with Coronary Artery Disease (OPERA): Study Design and Rationale
    Nakamura, Masato
    Nanto, Shinsuke
    Hirayama, Atsushi
    Takayama, Tadateru
    Nishikawa, Masakatsu
    Kimura, Kazuo
    Morita, Satoshi
    Aizawa, Tadanori
    Asano, Ryuta
    Matsumaru, Yuji
    Hamada, Chikuma
    Isshiki, Takaaki
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 84 (03) : 368 - 374
  • [36] Randomized, double-blind, multicenter study of the polymer-based 17-β estradiol-eluting stent for treatment of native coronary artery lesions:: Six-month results of the ETHOS I trial
    Abizaid, Alexandre
    Chaves, Aurea J.
    Leon, Martin B.
    Hauptmann, Karl
    Mehran, Roxana
    Lansky, Alexandra J.
    Baumbach, William
    Shankar, Hari
    Muller, Ralf
    Feres, Fausto
    Sousa, Amanda G. M. R.
    Sousa, J. Eduardo
    Grube, Eberhard
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 70 (05) : 654 - 660
  • [37] The US multicenter, randomized, double-blind study of the Sirolimus-eluting stent in coronary lesions: Early (30-day) safety results
    Moses, JW
    Leon, MB
    Popma, JJ
    Kuntz, RE
    CIRCULATION, 2001, 104 (17) : 464 - 464
  • [38] Multi-Center, Prospective, Randomized, Single-Blind, Consecutive Enrollment Evaluation of the Elixir DESyne® Novolimus-Eluting Coronary Stent System with Durable Polymer Compared to the Endeavor Zotarolimus-Eluting Coronary Stent System: Final Results from the EXCELLA II Study
    Verheye, Stefan
    Witzenbichler, Bernhard
    Dubois, Christophe
    Hauptmann, Karl-Eugen
    Ormiston, John A.
    Stewart, James T.
    Schofer, Joachim
    Stangl, Karl
    Fitzgerald, Peter J.
    Morrison, Lynn
    Toyloy, Sara
    Serruys, Patrick W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B173 - B173
  • [39] Randomized comparison of the efficacy of sirolimus-eluting stent versus paclitaxel-eluting stent in the treatment of long native coronary lesions: LONG-DES-II study
    Park, Seung-Jung
    Kim, Young-Hak
    Lee, Cheol Whan
    Hong, Myeong-Ki
    Kim, Hyun-Sook
    Ko, Jae-Ki
    Park, Jae-Yeong
    Lee, Jae-Hiwan
    Choi, Si-Wan
    Seong, Whan
    Lee, Seung-Whan
    Cho, Youn-Haeng
    Lee, Nae-Hee
    Park, Seong-Wook
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 142M - 142M
  • [40] Efficacy and safety at 3 years of the sirolimus-eluting stent for the treatment of patients with long lesions in small vessels from the Canadian multicenter, randomized, double-blind trial C-SIRIUS
    Schampaert, E
    Cohen, EA
    Reeves, F
    Palisaitis, DA
    Traboulsi, M
    Title, L
    O'Neill, BJ
    Raco, D
    Mildenberger, RR
    Plante, S
    Roy, L
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 53H - 54H
12345